← Back to guidelines
Pediatrics9 papers

Congenital adrenal hypoplasia, X-linked

Last edited: 4/14/2026

Overview

Congenital adrenal hypoplasia (CAH), particularly the X-linked form, is characterized by adrenal insufficiency often presenting with salt-wasting in neonates. Recent findings identify a new clinical association termed IMAGe, encompassing intrauterine growth retardation (IUGR), metaphyseal dysplasia, adrenal hypoplasia, and genital anomalies 12.

Diagnosis

  • Clinical Presentation: IUGR, dysmorphic features (frontal bossing, broad nasal bridge, low-set ears), short stature, metaphyseal dysplasia, adrenal insufficiency, and genital abnormalities 12.
  • Biochemical Tests: Elevated ACTH, low cortisol, and electrolyte imbalances (hyponatremia, hyperkalemia) 12.
  • Genetic Testing: Sequence analysis of DAX1/NR0B1 gene; normal sequences in IMAGe association suggest non-DAX1 etiology 2.
  • Imaging: Skeletal surveys to confirm metaphyseal dysplasia and assess for epiphyseal dysplasia 2.
  • Management

  • Hormonal Replacement: Glucocorticoids (e.g., hydrocortisone) and mineralocorticoids (e.g., fludrocortisone) tailored to replace deficient hormones 12.
  • Monitoring: Regular assessment of electrolytes, growth parameters, and pubertal development 12.
  • Supplementation: Consider calcium and vitamin D for patients with hypercalciuria or nephrocalcinosis 2.
  • Special Populations

  • Pediatrics: Early diagnosis and aggressive management of adrenal insufficiency are crucial to prevent morbidity 12.
  • Comorbidities: Presence of glycerol kinase deficiency (GKD) should be ruled out through biochemical testing, especially in cases with deletions in Xp21 3.
  • Key Recommendations

  • Genetic Evaluation: Perform genetic sequencing of DAX1/NR0B1 and consider Xp21 deletion analysis in cases of IMAGe association to exclude other contiguous gene syndromes (Evidence: Moderate) 2.
  • Comprehensive Management: Include hormonal replacement therapy with glucocorticoids and mineralocorticoids, alongside monitoring for skeletal and metabolic complications (Evidence: Moderate) 12.
  • Consider Additional Deficiencies: Evaluate for glycerol kinase deficiency in patients with Xp21 deletions to guide comprehensive management (Evidence: Weak) 3.
  • Inheritance Counseling: Offer genetic counseling due to potential autosomal recessive inheritance patterns identified in some cases (Evidence: Expert opinion) 4.
  • References

    1 Lienhardt A, Mas JC, Kalifa G, Chaussain JL, Tauber M. IMAGe association: additional clinical features and evidence for recessive autosomal inheritance. Hormone research 2002. link 2 Vilain E, Le Merrer M, Lecointre C, Desangles F, Kay MA, Maroteaux P et al.. IMAGe, a new clinical association of intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies. The Journal of clinical endocrinology and metabolism 1999. link 3 Oleesky DA, Hakeem V. Congenital adrenal hypoplasia and glycerol kinase deficiency. Acta paediatrica Scandinavica 1989. link 4 Burke BA, Wick MR, King R, Thompson T, Hansen J, Darrae BT et al.. Congenital adrenal hypoplasia and selective absence of pituitary luteinizing hormone: a new autosomal recessive syndrome. American journal of medical genetics 1988. link

    Original source

    1. [1]
      IMAGe association: additional clinical features and evidence for recessive autosomal inheritance.Lienhardt A, Mas JC, Kalifa G, Chaussain JL, Tauber M Hormone research (2002)
    2. [2]
      IMAGe, a new clinical association of intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.Vilain E, Le Merrer M, Lecointre C, Desangles F, Kay MA, Maroteaux P et al. The Journal of clinical endocrinology and metabolism (1999)
    3. [3]
      Congenital adrenal hypoplasia and glycerol kinase deficiency.Oleesky DA, Hakeem V Acta paediatrica Scandinavica (1989)
    4. [4]
      Congenital adrenal hypoplasia and selective absence of pituitary luteinizing hormone: a new autosomal recessive syndrome.Burke BA, Wick MR, King R, Thompson T, Hansen J, Darrae BT et al. American journal of medical genetics (1988)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG